These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30468658)

  • 1. Antioxidant therapies in attention deficit hyperactivity disorder.
    Moghadas M; Essa MM; Ba-Omar T; Al-Shehi A; Qoronfleh MW; Eltayeb EA; Guillemin GJ; Manivasagam T; Justin-Thenmozhi A; Al-Bulushi BS; Al-Adawi S; Edalatmanesh MA
    Front Biosci (Landmark Ed); 2019 Jan; 24(2):313-333. PubMed ID: 30468658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies.
    Lopresti AL
    Atten Defic Hyperact Disord; 2015 Dec; 7(4):237-47. PubMed ID: 25894292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
    Martinez-Raga J; Knecht C; Szerman N; Martinez MI
    CNS Drugs; 2013 Jan; 27(1):15-30. PubMed ID: 23160939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    Weibel S; Menard O; Ionita A; Boumendjel M; Cabelguen C; Kraemer C; Micoulaud-Franchi JA; Bioulac S; Perroud N; Sauvaget A; Carton L; Gachet M; Lopez R
    Encephale; 2020 Feb; 46(1):30-40. PubMed ID: 31610922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
    Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
    J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the Impact of Nutrition and Oxidative Stress on Attention Deficit Hyperactivity Disorder.
    Visternicu M; Rarinca V; Burlui V; Halitchi G; Ciobică A; Singeap AM; Dobrin R; Mavroudis I; Trifan A
    Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339712
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD).
    Dvoráková M; Sivonová M; Trebatická J; Skodácek I; Waczuliková I; Muchová J; Duracková Z
    Redox Rep; 2006; 11(4):163-72. PubMed ID: 16984739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.
    Wigal SB
    CNS Drugs; 2009; 23 Suppl 1():21-31. PubMed ID: 19621975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D's Molecular Action Mechanism in Attention-Deficit/ Hyperactivity Disorder: A Review of Evidence.
    Saedisomeolia A; Samadi M; Gholami F; Seyedi M; Effatpanah M; Hashemi R; Abdolahi M; Honarvar NM
    CNS Neurol Disord Drug Targets; 2018; 17(4):280-290. PubMed ID: 29714151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD).
    Pozzi M; Bertella S; Gatti E; Peeters GGAM; Carnovale C; Zambrano S; Nobile M
    Expert Opin Emerg Drugs; 2020 Dec; 25(4):395-407. PubMed ID: 32938246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample.
    Krakowski AD; Cost KT; Anagnostou E; Lai MC; Crosbie J; Schachar R; Georgiades S; Duku E; Szatmari P
    Mol Autism; 2020 Apr; 11(1):28. PubMed ID: 32334619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects.
    Golmirzaei J; Mahboobi H; Yazdanparast M; Mushtaq G; Kamal MA; Hamzei E
    Curr Pharm Des; 2016; 22(5):590-4. PubMed ID: 26601963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
    Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
    Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
    PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.